Catalent Inc - Company Profile
Powered by 
All the data and insights you need on Catalent Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Catalent Inc Strategy Report
- Understand Catalent Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Catalent Catalyst Calendar
Proactively evaluate Catalent Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Catalent Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 25 Nov 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 08 Nov 2019 | Phase II Trial Initiation | Catalent Inc; Johnson & Johnson; Thermo Fisher Scientific Inc | CTLT; JNJ; TMO | erdafitinib | Oncology | Bile Duct Cancer (Cholangiocarcinoma) ; Breast Cancer; Colorectal Cancer; Duodenal Cancer; Endometrial Cancer; Esophageal Cancer; Gastric Cancer; High-Grade Glioma; Low-Grade Glioma; Non-Small Cell Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Salivary Gland Cancer; Solid Tumor; Squamous Non-Small Cell Lung Cancer; Thyroid Cancer | Clinical Trial Registry |
| 30 Sep 2019 | Phase II Trial Results | Catalent Inc; EMD Serono Research & Development Institute Inc; Merck KGaA | CTLT; MRK | tepotinib hydrochloride | Oncology | Lung Adenocarcinoma; Lung Cancer; Non-Small Cell Lung Cancer; Squamous Non-Small Cell Lung Cancer | Company Presentation |
| 26 Aug 2019 | Phase III Trial Initiation | AstraZeneca Plc; Catalent Inc | AZN; CTLT | benralizumab | Respiratory | Chronic Obstructive Pulmonary Disease (COPD) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer